Proactive
Immunic to present additional Phase 2 data on vidofludimus calcium in progressive MS
📈
AI Sentiment
Highly Positive
8/10
Immunic Inc. News
Latest updates and market news for IMUX
2 news
Feb 3 - Feb 9, 2026
Page 1
PR Newswire
Immunic to Present Additional Phase 2 CALLIPER Trial Data for Vidofludimus Calcium at the ACTRIMS Forum 2026, Reinforcing Its Potential in Progressive Multiple Sclerosis
📈
AI Sentiment
Highly Positive
9/10
Share this news page